Plasma homocysteine concentrations in Mexican patients with ischemic heart disease;Concentraciones de homocisteína plasmática en pacientes mexicanos con cardiopatía isquémica

Revista de Investigacion Clinica

Volumn 56, Issue 5, 2004, Pages 580-585

  Montaño Loza, Aldo ^a   Meza Junco, Judith ^a   Valles, Victoria ^a   Castillo Martínez, Lilia ^a   Orea Tejeda, Arturo ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Acute myocardial infarction; Coronary atherosclerosis; Homocysteine; Risk factors

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CIGARETTE SMOKING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; EUROPE; FEMALE; HEART INFARCTION; HEART SCINTISCANNING; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEXICO; OBESITY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SOUTH AND CENTRAL AMERICA; UNITED STATES;

CASE-CONTROL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MEXICO; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

EID: 12444254026     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Mattila KJ, Valtonen VV, Nieminen MS, Asikainen S. Role of infection as a risk factor for atherosclerosis, myocardial infarction and stroke. Clin Infec Dis 1998; 26: 719-34.
2. Kullo IJ, Gau GT, Tajik AJ. Novel risk factors for atherosclerosis. Mayo Clin Proc 2000; 75: 369-80.
3. Meza-Junco J, Montaño-Loza A, Castillo-Martínez A, Orea-Tejeda A, Remes-Troche J, Villalobos-Zapata I. High prevalence of chlamydia pneumoniae seropositivity in mexican patients with ischemic heart disease. Arch Med Res 2004; 35: 318-23.
4. McCully K. Vascular pathology of homocysteinemia: implications for the pathogenesis of ateriosclerosis. Am J Pathol 1969; 56: 111-28.
5. McCully K. Ragsdale B. Production of ateriosclerosis by homocysteinemia. Am J Pathol 1970; 61: 1-11.
6. Nygard O, Nordrehaug J, Refsum H, Ueland P, Fastard M, Vollset S. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230-6.
7. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1985; 37: 1-31.
8. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-57.
9. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996; 27: 517-27.
10. Ueland PM. Homocysteine species as components of plasma redox thiol status. Clin Chem 1995; 41: 340-2.
11. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993; 39: 1764-79.
12. Nygard O, Refsum H, Ueland PM, Vollset SE. Mayor lifestyle determinants of plasma total homocysteine distribution: the Holland Homocysteine Study. Am J Clin Nutr 1998; 67: 263-70.
13. Omenns GS, Beresford SA, Motulsky AG. Preventing coronary heart disease: B vitamins and homocysteine. Circulation 1998; 5: 239-47.
14. Domagala TB, Undas A, Libura M, Szezklik A. Pathogenesis of vascular disease in hyperhomocysteinemia. J Cardiovasc Risk 1998; 5: 239-47.
15. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Ann Rev Med 1998; 49: 31-62.
16. Knekt P, Reunanen A, Alfthan G, Heliövaara M, Rissanen H, Marniemi J, et al. Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease. Arch Intern Med 2001; 161: 1589-94.
17. Wilcken DEL, Wilcken B. The pathogenesis of coronary artery disease: a possible role for methionine metabolism. J Clin Invest 1976; 57: 1079-82.
18. den Heijer M, Koster T, Blom HJ, Bos GM, Brier E, Reitsma PH, et al. Hyperhomocysteinemia as a risk factor for deep vein thrombosis. N Engl J Med 1996; 334: 759-62.
19. Rees MM, Rodgers GM. Homocysteinemia: association of metabolic disorder with vascular disease and thrombosis. Thromb Res 1993; 71: 337-59.
20. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma leves in health, disease, and drug therapy. J Lab Clin Med 1989; 114: 473-501.
21. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al. Total plasma homocysteine and cardiovascular risk profile. JAMA 1995; 274: 1526-33.
22. Christen WG, Ajani UA, Glynn RJ, Hennekens CH. Blood levels of homocysteine and increased risk of cardiovascular disease. Arch Intern Med 2000; 160: 422-34.
23. Savaria, MM, Bostem AG, Jacques PF, Selhub J, Rosenberg IH. Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis 2001; 150: 195-200.
24. Selhub J, Jacques P, Bostom A, D' Agostino R, Wilson P, Belanger A, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995; 332: 286-91.
25. Donner M, Klein G, Mathes P, Schwandt P, Richter W. Plasma total homocysteine levels in patients with early onset coronary heart disease and low cardiovascular profile. Metabolism 1998; 47: 273-9.
26. von Eckardstein A, Malinow MR, Upson B, Heinrich J, Schulte H, Schonfeld R, et al. Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as cardiovascular risk factor in men. Arterioscler Thromb 1994; 14: 460-4.
27. Olszewski AJ, Szostak WB. Homocysteine content of plasma proteins in ischemic heart disease. Atherosclerosis 1988; 69: 109-13.
28. Genest J Jr, McNamara JR, Salem DN, Wilson PWF, Schaefer EJ, Mainlow MR. Plasma homocysteine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990; 16: 1114-9.
29. Kang SS, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetethrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991; 48: 536-45.
30. Robinson K, Mayer EL, Miller DP, Green R, van Lente F, Gupta A, et al. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factor for coronary artery disease. Circulation 1995; 92: 2825-30.
31. Aronow WS, Ahn C. Association between plasma homocysteine and coronary artery disease in older persons. Am J Cardiol 1997; 80: 1216-8.
32. Verhoef P, Stamper MJ, Burning JE, Gaziano JM, Allen RH, Stabler SP, et al. Homocysteine metabolism and risk of myocardial infarction: relations with vitamins B6, B12, and folate. Am J Epidemiol 1996; 143: 845-59.
33. Manilow MR, Nieto FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA, et al. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol 1997; 17: 1157-62.
34. Christensen B, Frosst P, Lussier-Cacan S, Selhub J, Goyett P, Rosenblatt DS et al. Correlation of a common mutation in methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vasc Biol 1997; 17: 569-73.
35. Schwartz SM, Siscovick DS, Malinow MR, Rosendaal FR, Beverly K, Hessdl et al. Myocardial infarction in young women in relation to plasma total homocysteine, folate, an a common variant in the metilentetrahydrofolate reductase gene. Circulation 1997; 96: 412-7.
36. Wu LL, Wu J, Hunt SC, James BC, Vincent GM, Williams R, et al. Plasma homocysteine as a risk factor for early familial coronary artery disease. Clin Chem 1994; 40: 552-61.
37. Malinow MR, Ducimetiere P, Luc G, Evans AE, Arveyler D, Cambien F et al. Plasma homocysteine levels an grated risk for myocardial infarction: Finding in two populations and a contrasting risk for coronary heart disease. Atherosclerosis 1996; 126: 27-34.
38. Loehrer FMT, Angst CP, Haefeli WE, Jordan PP, Ritz R, Fowler B. Low whole-blood S-adenosyl-methionine and correlation between 5-methiletrahidrofolate and homocysteine in coronary artery disease. Arterioscler Thromb Vasc Biol 1996; 16: 727-33.
39. Kang SS, Wong PWK, Cook HY, Norusis M, Messer JD. Protein-bound homocysteine. A possible risk factor for coronary artery disease. J Clin Invest 1986; 77: 1482-6.
40. Ubbink JB, Vermaak WJH, Benett JM, Becker S, Van Staden DA, Bissbort S. The prevalence of the homocysteinemia and hypercholesterolemia in angiographically define coronary heart disease. Klin Wochenschr 1991; 69: 527-34.
41. Montalescot G, Ankri A, Chadefeaux-Vekemans B, Blacher J, Philip F, Drohinski G, et al. Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease. Int J Cardiol 1997; 60: 295-300.
42. Dalery K, Lussier-Cacan S, Selhub J, Davignon J, Latour Y, Genest J Jr. Homocysteine and coronary artery disease in French Canadian subjects: relations with vitamins B12, B6, pyridoxal phosphate, and folate. Am J Cardiol 1995; 75: 1107-11.
43. Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RCP, Alvarez JO, et al. Plasma homocysteine, folate, and vitamin B-12 concentrations and risk for early onset coronary artery disease. Am J Clin Nutr 1994; 59: 940-8.
44. Graham IM, Daly LE, Refsum HM, Robisnon K, Brattström LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277: 1775-81.
45. Kluijtmans LAJ, van den Heuvel LPW, Borres GHJ, Frosst P, Stevens EMB, van Oust BA, et al. Molecular genetic analysis in mild hyperhomocystinemia. A common mutation in the metilentetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58: 35-41.
46. Lolin YI, Sanderson JE, Cheng SK, Chan CF, Pang CP, Woo KS, et al. Hyperhomocysteinaemia and premature coronary artery disease in the Chinese. Heart 1996; 76: 117-22.
47. Verhoef P, Kok FJ, Kruyssen DACM, Schouten EG, Witteman JCM, Grobbee DE, et al. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 989-95.
48. Israelsson B, Brattström LE, Hultberg BL. Homocysteine and myocardial infarction. Artherosclerosis 1988; 71: 277-33.
49. Clarke R, Daly L, Robinson K, Naughyen E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: and independet risk factor for vascular disease. N Engl J Med 1991; 342: 1149-55.
50. Murphy-Chutorian DR, Wexman MP, Grieco AJ, Heininger JA, Glassman E, Graull GE, et al. Methionine intolerance: a possible risk factor for coronary artery disease. J Am Coll Cardiol 1985; 6: 725-30.
51. Schmitz C, Lindpainntner K, Verhoef P, Gaziano JM, Buring J. Genetic poly-morphism of metilentetrahydrofolate reductase and myocardial infarction. A case-control study. Circulation 1996; 94: 1812: 4.
52. Kang SS, Passen EL, Ruggie N, Wong PWK, Sora H. Thermolabile defect of metilentetrahydrofolate reductase in coronary heart disease. Circulation 1993; 88: 1463-9.
53. Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM. Homocysteine and ischemic heart disease. Results of a prospective study with implications regarding prevention. Arch Intern Med 1998; 158: 862-7.
54. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an ederly population. JAMA 1993; 270: 2693-8.
55. Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJC, Jakobs C, Bouter LM, et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 1998; 18: 133-8.
56. Jacques PF, Rosenberg IH, Rogers G, Selhub J, Bowman BA, Gunter EW, et al. Serum total homocysteine, concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey1-4. Am J Clin Nutr 1999; 69: 482-9.
57. Ganji V, Kafai MR. Third National Health and Nutrition Examination Survey. Demographic, health, lifestyle, and blool vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2003; 77: 826-33.
58. Tovar AR, Torres N, Barrales-Benitez O, Lopez AM, Diaz M, Rosado JL. Plasma total homocysteine in Mexican rural and urban women fed typical model diets. Nutrition 2003; 19: 826-31.
59. Morales JJ, Sanchez B, Verdejo J, Ponce de Leon S, Mutchinick OM. Hyperhomocysteinemia as risk factor in a Mexican population. Arch Cardiol Mex 2003; 73(Suppl. 1): S103-5.
60. Esfahani ST, Cogger EA, Caudill MA. Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups. J Am Diet Assoc 2003; 103: 200-7.